跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
D-Pinitol
首页
药物
D-Pinitol
D-Pinitol
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITION AND METHODS FOR ENHANCING OR PROMOTING THE SECRETION OF GHRELIN TO PROMOTE A HEALTHY METABOLIC AGING
EP 3789018 A1
申请人: SERVICIO ANDALUZ DE SALUD
优先权: 2019
CN
EP
US
WO
7 件公开
Compositions and methods for treating alzheimer's disease and related disorders and promoting a healthy nervous system
US 8193250 B2
申请人: PASINETTI GIULIO M
优先权: 2005
US
6 件公开
Composition for alleviating, preventing or treating female menopausal symptoms, containing, as active ingredient, pinitol, D-chiro-inositol or analog compounds thereof
US 11040016 B2
申请人: DY NATURAL CO LTD
优先权: 2016
CN
US
2 件公开
Methods for the production of D-chiro-inositol and the use of D-chiro-inositol obtained therefrom
US 2002023877 A1
申请人: JOHNSON LELAND L
优先权: 2001
US
2 件公开
Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
US 7393551 B2
申请人: INVEST Y NUTRICION S L
优先权: 2002
US
2 件公开
Composition for prevention or treatment of bone metabolism disorder comprising D-pinitol as an active ingredient
US 8273718 B2
申请人: RHO JAERANG
优先权: 2007
US
2 件公开
Performance enhancing composition and method of delivering nutrients
US 8999424 B2
申请人: FERRANTE RALPH MARIO
优先权: 2011
US
2 件公开
US 2015196579 A1
申请人: ADVANCED BIO DEV INC
优先权: 2015
US
2 件公开
Composition and method for enhancing or promoting the activity of insulin, enhancing skeletal muscle growth, reducing skeletal muscle loss, and increasing the energy supply to skeletal muscle
US 2008058254 A1
申请人: HEUER MARVIN A
优先权: 2006
US
Health-care product containing D-pinitol and having blood glucose lowering function and function assessment method
CN 104605349 A
申请人: UNIV TIANJIN SCIENCE & TECH
优先权: 2015
CN
Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases, application of pharmaceutical composition and injection prepared from pharmaceutical composition
CN 107550923 A
申请人: LANGZHI GROUP JIANGXI MEDICINE CO LTD
优先权: 2017
CN
第 1 / 2 页
上一页
下一页
药物
反馈